TIS 0.00% 0.0¢ tissue therapies limited

Cash Flow

  1. 427 Posts.
    lightbulb Created with Sketch. 7
    That seems to be a lot of money spent on product development when A) we are supposed to be conserving cash, and b) I thought we were supposed to have a product and were just focused on getting that to market. Of course there may be a legitimate reason, and in our new age of transparency I would like to know what is going on. Anyone like to elaborate? It looks like nothing much has altered by the look of the expenditure on this balance sheet. I'm sure we will be kept more informed, because Ms Hirst said so. Regards, Mushroom.
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.